| Year |
Citation |
Score |
| 2018 |
Foster JG, Wood SK, Pfeffer MA, DeMets DL, Garber A, Hennekens CH. ASPIRIN FOR PRIMARY PREVENTION IN PATIENTS WITH TYPE 2 DIABETES. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. PMID 29975578 DOI: 10.4158/Ep-2018-0073 |
0.315 |
|
| 2016 |
Freeman JV, Hutton DW, Barnes GD, Zhu RP, Owens DK, Garber AM, Go AS, Hlatky MA, Heidenreich PA, Wang PJ, Al-Ahmad A, Turakhia MP. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL. Circulation. Arrhythmia and Electrophysiology. 9. PMID 27307517 DOI: 10.1161/CIRCEP.115.003407 |
0.45 |
|
| 2014 |
Khazeni N, Hutton DW, Collins CI, Garber AM, Owens DK. Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study. Annals of Internal Medicine. 160: 684-94. PMID 24842415 DOI: 10.7326/M13-2071 |
0.394 |
|
| 2014 |
Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL. Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial". Circulation. 129: e460-1. PMID 24753557 DOI: 10.1161/Circulationaha.113.008033 |
0.35 |
|
| 2014 |
Kazi DS, Garber AM, Shah RU, Dudley RA, Mell MW, Rhee C, Moshkevich S, Boothroyd DB, Owens DK, Hlatky MA. Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome. Annals of Internal Medicine. 160: 221-32. PMID 24727840 DOI: 10.7326/M13-1999 |
0.455 |
|
| 2013 |
Simons CT, Cipriano LE, Shah RU, Garber AM, Owens DK, Hlatky MA. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circulation. Cardiovascular Quality and Outcomes. 6: 419-28. PMID 23838104 DOI: 10.1161/CIRCOUTCOMES.113.000280 |
0.384 |
|
| 2013 |
Erickson KF, Japa S, Owens DK, Chertow GM, Garber AM, Goldhaber-Fiebert JD. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. Journal of the American College of Cardiology. 61: 1250-8. PMID 23500327 DOI: 10.1016/j.jacc.2012.12.034 |
0.465 |
|
| 2013 |
Garber A, Abrahamson M, Barzilay J, Blonde L, Bloomgarden Z, Bush M, Dagogo-Jack S, Davidson M, Einhorn D, Garvey W, Grunberger G, Handelsman Y, Hirsch I, Jellinger P, McGill J, et al. American association of clinical endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement Endocrine Practice. 19: 1-48. DOI: 10.4158/Ep13176.Csuppl |
0.314 |
|
| 2012 |
Kazi D, Garber AM, Shah R, Rhee C, Moshkevich S, Mell MW, Boothroyd D, Owens DK, Hlatky M. PANACEA OR PERSONALIZED MEDICINE? OPTIMIZING ANTIPLATELET THERAPY IN ACUTE CORONARY SYNDROME – A COST-EFFECTIVENESS ANALYSIS Journal of the American College of Cardiology. 59: E348. DOI: 10.1016/S0735-1097(12)60349-0 |
0.45 |
|
| 2011 |
Sharma MD, Farmer JA, Garber A. Type 2 diabetes and cardiovascular risk factors. Current Medical Research and Opinion. 27: 1-5. PMID 22106974 DOI: 10.1185/03007995.2011.620083 |
0.305 |
|
| 2011 |
Park KT, Perez F, Tsai R, Honkanen A, Bass D, Garber A. Cost-effectiveness analysis of adjunct VSL#3 therapy versus standard medical therapy in pediatric ulcerative colitis. Journal of Pediatric Gastroenterology and Nutrition. 53: 489-96. PMID 21694634 DOI: 10.1097/Mpg.0B013E3182293A5E |
0.38 |
|
| 2011 |
Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Annals of Internal Medicine. 154: 1-11. PMID 21041570 DOI: 10.7326/0003-4819-154-1-201101040-00289 |
0.413 |
|
| 2010 |
Bode BW, Testa MA, Magwire M, Hale PM, Hammer M, Blonde L, Garber A. Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes. Diabetes, Obesity & Metabolism. 12: 604-12. PMID 20590735 DOI: 10.1111/J.1463-1326.2010.01196.X |
0.335 |
|
| 2010 |
Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM. Population strategies to decrease sodium intake and the burden of cardiovascular disease: A cost-effectiveness analysis Annals of Internal Medicine. 152: 481-487. PMID 20194225 DOI: 10.7326/0003-4819-152-8-201004200-00212 |
0.452 |
|
| 2010 |
Perlroth DJ, Glass RJ, Davey VJ, Cannon D, Garber AM, Owens DK. Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States Clinical Infectious Diseases. 50: 165-174. PMID 20021259 DOI: 10.1086/649867 |
0.471 |
|
| 2010 |
Levesque BG, Cipriano LE, Chang SL, Lee KK, Owens DK, Garber AM. Cost Effectiveness of Alternative Imaging Strategies for the Diagnosis of Small-Bowel Crohn's Disease Clinical Gastroenterology and Hepatology. 8. PMID 19896559 DOI: 10.1016/j.cgh.2009.10.032 |
0.484 |
|
| 2009 |
Plutzky J, Garber A, Falahati A, Toft AD, Poulter NR. Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis. Canadian Journal of Diabetes. 33: 209-210. PMID 25998594 DOI: 10.1016/S1499-2671(09)33072-5 |
0.312 |
|
| 2009 |
Khazeni N, Hutton DW, Garber AM, Owens DK. Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic Annals of Internal Medicine. 151: 840-853. PMID 20008760 DOI: 10.7326/0003-4819-151-12-200912150-00156 |
0.476 |
|
| 2009 |
Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK. Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009 Annals of Internal Medicine. 151: 829-839. PMID 20008759 DOI: 10.7326/0003-4819-151-12-200912150-00157 |
0.462 |
|
| 2009 |
Arrow K, Auerbach A, Bertko J, Brownlee S, Casalino LP, Cooper J, Crosson FJ, Enthoven A, Falcone E, Feldman RC, Fuchs VR, Garber AM, Gold MR, Goldman D, Hadfield GK, et al. Toward a 21st-century health care system: recommendations for health care reform. Annals of Internal Medicine. 150: 493-5. PMID 19258550 DOI: 10.7326/0003-4819-150-7-200904070-00115 |
0.618 |
|
| 2009 |
Garber A, Henry R, Ratner R, Garcia-Hernandez PA, Rodriguez-Pattzi H, Olvera-Alvarez I, Hale PM, Zdravkovic M, Bode B. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial. Lancet (London, England). 373: 473-81. PMID 18819705 DOI: 10.1016/S0140-6736(08)61246-5 |
0.318 |
|
| 2009 |
Garber A, Henry R, Ratner RE, Hale P, Chang CT, Bode B. Two years of treatment with liraglutide, a human GLP-1 analogue, offers sustained and greater reduction with HbA1c, FPG, PPG and weight compared with glimepiride, with lower glycaemic risk, in patients with type 2 diabetes: LEAD-3 extension study Canadian Journal of Diabetes. 33: 289. DOI: 10.1016/S1499-2671(09)33265-7 |
0.331 |
|
| 2009 |
Levesque BG, Cipriano LE, Chang SL, Lee KK, Owens DK, Garber AM. 653 Cost-Effectiveness of Alternative Diagnostic Strategies for Patients with Suspected Small-Bowel Crohn's Disease Gastroenterology. 136: A-100. DOI: 10.1016/S0016-5085(09)60448-0 |
0.469 |
|
| 2008 |
Desai AA, Baras J, Berk BB, Nakajima A, Garber AM, Owens D, Chertow GM. Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis. Archives of Internal Medicine. 168: 1761-7. PMID 18779463 DOI: 10.1001/Archinte.168.16.1761 |
0.502 |
|
| 2008 |
Sharma SK, Yeo JP, Garber A. Lessons in initiating insulin in clinical practice Diabetes Research and Clinical Practice. 81. PMID 18672308 DOI: 10.1016/J.Diabres.2008.06.009 |
0.304 |
|
| 2008 |
Garber A. Response to Pokharna and Kanna: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes Diabetes, Obesity and Metabolism. 10: 436-437. PMID 17596200 DOI: 10.1111/J.1463-1326.2007.00722.X |
0.326 |
|
| 2007 |
Ray JA, Valentine WJ, Roze S, Nicklasson L, Cobden D, Raskin P, Garber A, Palmer AJ. Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US. Diabetes, Obesity & Metabolism. 9: 103-13. PMID 17199725 DOI: 10.1111/J.1463-1326.2006.00581.X |
0.405 |
|
| 2006 |
Rosenstock J, Rood J, Cobitz A, Biswas N, Chou H, Garber A. Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes. Diabetes, Obesity and Metabolism. 8: 650-660. PMID 17026489 DOI: 10.1111/J.1463-1326.2006.00659.X |
0.334 |
|
| 2006 |
Rosenstock J, Rood J, Cobitz C, Huang A, Garber A. Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control Diabetes, Obesity and Metabolism. 8: 643-649. PMID 17026488 DOI: 10.1111/J.1463-1326.2006.00648.X |
0.337 |
|
| 2006 |
Liu H, Michaud K, Nayak S, Karpf DB, Owens DK, Garber AM. The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis Archives of Internal Medicine. 166: 1209-1217. PMID 16772249 DOI: 10.1001/archinte.166.11.1209 |
0.48 |
|
| 2006 |
Garber A, Klein E, Bruce S, Sankoh S, Mohideen P. Metformin‐glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy Diabetes, Obesity and Metabolism. 8: 156-163. PMID 16448519 DOI: 10.1111/J.1463-1326.2005.00570.X |
0.314 |
|
| 2005 |
Fowler RA, Sanders GD, Bravata DM, Nouri B, Gastwirth JM, Peterson D, Broker AG, Garber AM, Owens DK. Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax. Annals of Internal Medicine. 142: 601-10. PMID 15838066 DOI: 10.7326/0003-4819-142-8-200504190-00008 |
0.44 |
|
| 2005 |
Cobden D, Nicklasson L, Raskin P, Garber A, Ray J, Valentine W, Palmer A, Roze S. Pdb26 Comparative Evaluation Of The Long-Term Cost-Effectiveness Of Biphasic Insulin Aspart 30 And Insulin Glargine In A Sub-Population Of Poorly Controlled Patients With Type-2 Diabetes Receiving Oral Antidiabetic Agents Value in Health. 8. DOI: 10.1016/S1098-3015(10)67645-0 |
0.34 |
|
| 2003 |
Yock CA, Boothroyd DB, Owens DK, Garber AM, Hlatky MA. Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. The American Journal of Medicine. 115: 382-9. PMID 14553874 DOI: 10.1016/S0002-9343(03)00296-1 |
0.431 |
|
| 2003 |
Garber A, Marre M, Blonde L, Allavoine T, Howlett H, Lehert P, Cornes M. Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance®) in type 2 diabetes Diabetes, Obesity and Metabolism. 5: 171-179. PMID 12681024 DOI: 10.1046/J.1463-1326.2003.00259.X |
0.311 |
|
| 2002 |
Grundy SM, Garber A, Goldberg R, Havas S, Holman R, Lamendola C, Howard WJ, Savage P, Sowers J, Vega GL. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors Circulation. 105. PMID 11994266 DOI: 10.1161/01.Cir.0000014022.85836.96 |
0.317 |
|
| 2000 |
Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease American Journal of Gastroenterology. 95: 395-407. PMID 10685741 DOI: 10.1111/J.1572-0241.2000.01759.X |
0.354 |
|
| 1996 |
Owens DK, Holodniy M, Garber AM, Scott J, Sonnad S, Moses L, Kinosian B, Schwartz JS. Polymerase chain reaction for the diagnosis of HIV infection in adults. A meta-analysis with recommendations for clinical practice and study design. Annals of Internal Medicine. 124: 803-15. PMID 8610949 DOI: 10.7326/0003-4819-124-9-199605010-00004 |
0.378 |
|
| Show low-probability matches. |